- Adroit Industries IPO surged 86.57% on its listing day..
- Elevate Campus debuted with a 1.52% discount from IPO price.
- Swastika Infra and ArMee Infotech experienced moderate to subdued listings.
The shares of four companies–Adroit Industries, Elevate Campus, Swastika Infra, and ArMee Infotech–whose mainboard IPOs concluded last week made their stock market debut on Wednesday, September 30. Of the companies with positive listings, one surged 86.57 per cent on listing day, while one listed in red and flat, respectively.
Adroit Industries IPO Listing
Adroit Industries delivered the strongest listing gains among the debuts. Its shares opened at Rs 250 on the BSE—a strong premium of Rs 116 (86.57%) over its issue price of Rs 134. On the NSE, the stock debuted at Rs 235, marking a 75.37% gain.
Overall, the public issue of Adroit Industries was subscribed 176.85 times.
Elevate Campus IPO Listing
In contrast, Elevate Campus made a weak stock market debut. On the BSE, the shares listed at Rs 356.50, down Rs 5.50 (1.52%) from the IPO price of Rs 362. The stock opened on the NSE at Rs 355.10, representing a 1.91% discount.
The IPO of Elevate Campus was subscribed 1.89 times by the close of bidding.
Swastika Infra IPO Listing
Swastika Infra posted moderate positive returns on debut. The stock listed at Rs 200 on both the BSE and NSE, translating to a premium of Rs 15, or 8.11%, compared to its issue price of Rs 185.
Swastika Infra's issue saw an overall subscription of 7.91 times.
ArMee Infotech IPO Listing
ArMee Infotech experienced a subdued debut. On the NSE, the stock opened flat at its issue price of Rs 375. However, it debuted at Rs 368.85 on the BSE—a discount of Rs 6.15, or 1.64%.
Overall, ArMee Infotech's IPO received 2.62 times subscription.
Conclusion
The market lising of these stocks were one line of market expectations as their shares showedkind of similar expected listing gain in grey market. The IPOs made debut amid volatility in stock market.
Disclaimer: This story is for informational purposes only. It should not be considered as invetsment advice.